2m 2m 2m 2m 2m 2m 2m
IMMIX BIOPHARMA (IMMX)
NASDAQ
$8.63+$0.26 (+3.11%)
Price as of Jun 03, 2026 7:41 PM EDT- $640.7MMarket Cap
- 296.45%1-Year Change
- BiotechnologyIndustry
IMMIX BIOPHARMA (IMMX)
$8.63+$0.26 (+3.11%)
IMMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.37 | ||
Change | -$0.85 (-9.27%) | ||
Open | $9.20 | ||
High | $9.34 | ||
Low | $8.23 | ||
Previous Close | $9.22 | ||
Volume | 1,380,406 | ||
30-Day Average Volume | 1,365,550 | ||
1-Week Change | -5.37% | ||
1-Month Change | -10.05% | ||
1-Year Change | 296.45% | ||
3-Year Change | 310.05% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 71.2M | ||
Total Assets | $95.8M | ||
Market Cap | $640.7M | ||
Enterprise Value | $561.5M | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$10.1M | ||
Free Cash Flow | -$9.9M | ||
EBIT | -$10.1M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $81.7M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -56 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 8 | ||
P/E | -50 | ||
PEG | -2 | ||
Price/Free Cash Flow | -65 | ||
Price/Operating Cash Flow | -65 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue